Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 January 2025 | Story Lunga Luthuli | Photo Supplied
Intsika Food Garden
The newly redeveloped Intsika Garden on the UFS Qwaqwa Campus, designed to promote accessibility, sustainability, and community engagement. The garden's flexible spaces offer opportunities for students to relax, collaborate, and connect with one another.

The UFS Qwaqwa Campus is transforming its landscape to provide more than just a physical connection between buildings. The redevelopment of the garden in front of the Intsika Building marks a shift towards integrating communal spaces that support interaction, inclusivity, and sustainability. 

According to Nico Janse van Rensburg, Senior Director: Facilities Planning at University Estates, the primary aim of the redevelopment is to celebrate the diversity of the university as its ‘greatest asset’ by creating spaces that promote community engagement. “Previously, the garden was underutilised and did not connect properly to the rest of the campus’ circulation network. We identified an opportunity to develop it into a social space where academia and visitors can connect,” Van Rensburg explained.  

Accessibility and sustainability  

The Intsika Garden redevelopment aligns with the broader strategic goals of the institution, particularly in infrastructure planning. The project focuses on making the space universally accessible, ensuring that it caters for people with disabilities while improving overall circulation on the campus. “The development strives to improve the accessibility to different functions on the campus by making the space and circulation routes universally accessible,” said Van Rensburg.  

This initiative is also embedded in the university’s commitment to sustainability, as waterwise plants, artificial grass, and low maintenance finishes have been carefully selected to reduce the environmental footprint. “Artificial grass was used in combination with natural vegetation, which requires minimal water and maintenance,” he added.  

In addition to accessibility, sustainability plays a central role in the redevelopment. The project is designed to contribute to the university’s goal of reducing its carbon footprint by promoting pedestrian-friendly spaces and minimising the reliance on fossil-fuel-driven vehicles.  

Van Rensburg highlighted the efficiency gains in the management of green spaces, noting that the design will reduce the frequency of maintenance, which in turn reduces carbon emissions and energy consumption. “By promoting pedestrian circulation and integration with public transport, the use of vehicles using fossil fuels is minimised,” he said. Walking, he added, is not only a more environmentally friendly option, but also promotes the health and well-being of the campus community.  

Social spaces for collaboration  

The redevelopment introduces six new social nodes across the campus, each offering unique opportunities for student engagement and collaboration. “Smaller pockets have been created, which form part of the larger public space, resulting in a microclimate where people can relax and socialise,” Van Rensburg explained.  

The spaces are designed with flexibility in mind, featuring various seating arrangements, including spaces for meetings and group collaborations. Among the new additions is an amphitheatre, which provides a multifunctional space for lectures, performances, and other activities. “Flexible communal spaces were created for recreational opportunities, resulting in a balanced campus lifestyle,” Van Rensburg added.  

Recognising the increasing reliance on technology, the redevelopment also incorporates features such as charging stations and Wi-Fi connectivity. The spaces are envisioned as ‘information zones’, providing students and staff with convenient access to online resources while they relax or connect outdoors. “With Wi-Fi connectivity, the spaces function as an extension to traditional libraries,” noted Van Rensburg.   

While the Intsika Garden redevelopment is a significant step forward, plans are already underway for further infrastructure and green initiatives. “The soft landscaping and signage contracts were awarded for the Intsika Garden,” Van Rensburg confirmed. He also revealed that much-needed renovations to the front of the Intsika Building are in the pipeline, with a contractor soon to be appointed for the construction work. The planned upgrade will align with the garden’s aesthetics by drawing inspiration from indigenous art and culture, creating a cohesive identity for the campus. 

As these developments progress into 2025, the Qwaqwa Campus will continue to evolve, offering students and staff spaces that not only enhance their academic experience, but also contribute to a more sustainable and connected environment. 

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept